A New Challenge—and Opportunity—in Glaucoma

From the Editor: The way that surgeons present the disease and its treatments can help patients achieve their best outcomes.

Nathan M. Radcliffe, MD

Glaucoma Physician September 1, 2025 Page(s): 1

Clinical Report: A New Challenge—and Opportunity—in Glaucoma

Overview

This report discusses the complexities of effectively communicating glaucoma diagnosis and treatment options to patients. It highlights the need for a shift in patient education to improve treatment acceptance and outcomes, particularly regarding the risks associated with long-term topical therapy.

Background

Effective communication in glaucoma management is crucial for optimizing patient outcomes. Patients often perceive topical medications as benign, which can lead to over-reliance on these therapies despite their potential side effects. Understanding the disease's progression and treatment options is essential for both clinicians and patients to navigate the complexities of glaucoma care.

Data Highlights

No numerical data provided in the source material.

Key Findings

Patients often feel empowered by using topical medications, despite the associated risks.
Long-term topical therapy can lead to side effects such as cataract formation and dry eye.
Minimally invasive glaucoma surgery (MIGS) and sustained delivery systems may replace topical therapy effectively.
Motivating patients to accept alternative therapies during the asymptomatic phase of glaucoma is a significant challenge.
Advancements in diagnostics could enhance individualized treatment approaches.

Clinical Implications

Clinicians should prioritize clear communication about the risks of long-term topical therapy and present alternative treatment options early in the disease process. Tailoring discussions to emphasize the direct treatment of the disease's underlying mechanisms may improve patient acceptance of new therapies.

Conclusion

A paradigm shift in how glaucoma is presented to patients is necessary to enhance treatment acceptance and outcomes. By focusing on the implications of long-term therapy and available alternatives, healthcare providers can better support their patients.

PentaVision

Glaucoma Physician